Guess which ASX lithium share just leapt 32% on big news out of the US

The small-cap lithium share entered a trading halt on Friday pending the announcement of a proposed new project.

| More on:
Man pointing at a blue rising share price graph.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • The Mandrake Resources share price surged 32% in early morning trade
  • The ASX lithium share secured a large-scale lithium project in the US state of Utah
  • Galan Lithium is investing $1.5 million for a 5% stake in Mandrake and will be involved in the project

ASX lithium share Mandrake Resources Ltd (ASX: MAN) is defying the broader market sell-off today and racing ahead.

The small-cap lithium stock entered a trading halt on Friday pending the announcement of a proposed new project. Shares resumed trading this morning following on from that announcement.

The Mandrake share price closed on Thursday trading for 5.3 cents. In early morning trading today, the ASX lithium share was trading for 7 cents, up a whopping 32%.

There's been some profit-taking since then, with Mandrake shares currently changing hands for 6.3 cents, up 19%.

Here's what's piquing investor interest today.

What's spurring investor interest in the ASX lithium share?

The Mandrake Resources share price is soaring after the company reported it has secured a large-scale lithium project in the "lithium four corners" Paradox Basin, located in the US state of Utah.

The project covers some 56,000 acres (approximately 226 square kilometres) of lithium brine prospective ground. This includes a binding agreement with the Utah state government for more than 34,000 acres.

With staking still taking place, the ASX lithium share said it would update the market with any increases in the project's size.

A lithium exploration target could potentially be generated in the short term, with Mandrake working towards a maiden Mineral Resource in the second half of 2023.

Commenting on the news that's sending the ASX lithium share rocketing today, Mandrake managing director James Allchurch said:

Mandrake has organically secured a potentially world-class lithium project in the heart of the US, at a time when the US federal government is actively funding and supporting domestic sources of strategic and critical materials such as lithium.

Utah is among the most mining and investment friendly jurisdictions in the US with the state government heavily involved in aiding Utah-based projects play a role in the global energy transition from fossil fuels to renewable energy.

The project has also garnered interest from Galan Lithium Ltd (ASX: GLN).

"The opportunity presented by Mandrake's large-scale Utah Lithium Project is clearly recognised by ASX lithium developer Galan Lithium," Allchurch added.

Galan Lithium is investing $1.5 million for a 5% stake in Mandrake and "will be involved in the project on an ongoing basis in a technical advisory capacity".

Galan's 5% stake comes through the subscription of 30 million shares at 5 cents per share, escrowed for 12 months.

Galan managing director Juan Pablo Vargas de la Vega commented:

The large-scale potential of Mandrake's Utah Lithium Project situated in an extremely attractive jurisdiction boasting power and water infrastructure in the lithium-hungry United States presented a compelling opportunity for Galan to gain early-stage exposure.

Mandrake reported that it is fully funded, with $19 million in cash post the Galan placement.

Mandrake Resources share price snapshot

As you can see in the chart below, the Mandrake share price is no stranger to some big daily moves.

At the time of writing, the ASX lithium share is up a healthy 22% over the past 12 months.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Stock market chart in green with a rising arrow symbolising a rising share price.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a massive day for the ASX 200, with a new all-time high recorded.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

This ASX tech stock rocketed 60% in March! Can it keep on delivering?

After soaring in March, the ASX tech stock is now up 169% since this time last year.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Mesoblast, Newmont, Pilbara Minerals, and Platinum shares are jumping

These ASX shares are ending the week strongly. But why?

Read more »

A young male ASX investor raises his clenched fists in excitement because of rising ASX share prices today
Share Gainers

3 ASX All Ords shares up 50%+ in March

These ASX shares have been on fire this month. But why?

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Share Gainers

Why Mesoblast, Patriot Battery Metals, Sigma, and Zip shares are pushing higher

These shares are having a good session on hump day. But why?

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Consumer Staples & Discretionary Shares

If you'd put $20,000 in this ASX retail stock at the start of 2023, you'd have $134,000 now

This online retailer has executed a remarkable turnaround for its investors.

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to earth for ASX shares this Tuesday.

Read more »

Two happy scientists analysing test results.
Healthcare Shares

Mesoblast share price rockets 36% on breaking FDA news

ASX investors are sending the Mesoblast share price soaring following promising FDA news.

Read more »